000 01722 a2200481 4500
005 20250518053426.0
264 0 _c20201027
008 202010s 0 0 eng d
022 _a1471-2369
024 7 _a10.1186/s12882-019-1469-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNagarajah, Subagini
245 0 0 _aReduced membrane attack complex formation in umbilical cord blood during Eculizumab treatment of the mother: a case report.
_h[electronic resource]
260 _bBMC nephrology
_c08 2019
300 _a307 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal, Humanized
_xmetabolism
650 0 4 _aAtypical Hemolytic Uremic Syndrome
_xdrug therapy
650 0 4 _aComplement C3
_xmetabolism
650 0 4 _aComplement C5a
_xmetabolism
650 0 4 _aComplement C9
_xmetabolism
650 0 4 _aComplement Inactivating Agents
_xmetabolism
650 0 4 _aComplement Membrane Attack Complex
_xdrug effects
650 0 4 _aEnzyme-Linked Immunosorbent Assay
_xmethods
650 0 4 _aFemale
650 0 4 _aFetal Blood
_ximmunology
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aKidney Failure, Chronic
_xdrug therapy
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications
_xdrug therapy
650 0 4 _aRecurrence
700 1 _aTepel, Martin
700 1 _aNielsen, Christian
700 1 _aAssing, Kristian
700 1 _aPalarasah, Yaseelan
700 1 _aAndersen, Lise Lotte Torvin
700 1 _aLange, Lotte Borg
700 1 _aBistrup, Claus
773 0 _tBMC nephrology
_gvol. 20
_gno. 1
_gp. 307
856 4 0 _uhttps://doi.org/10.1186/s12882-019-1469-9
_zAvailable from publisher's website
999 _c29984274
_d29984274